The subsets of T cells (CD4+, CD8+, FOXP3+(forkhead box protein 3), and PD-1+(programmed death molecule 1)) infiltrating breast cancer, however, can have different pathobiological significance and prognostic characteristics and are a matter of continuing debate [2, 5, 12–16]. The gene discussed is CD4; the disease is breast carcinoma.